NAYUKI (02150) spent 373,900 Hong Kong dollars to repurchase 486,000 shares on June 16th.
Nai Xue Tea (02150) announced that it will spend HK$373,900 to repurchase 486,000 shares on June 16, 2026.
Nayuki (02150) announced on June 16, 2026 that it will spend HK$373,900 to repurchase 486,000 shares.
Related Articles
LYUE PHARMA (02186) innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has achieved positive results in the Phase II clinical trial for the treatment of delayed onset movement disorders in China.
IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.
Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.
LYUE PHARMA (02186) innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has achieved positive results in the Phase II clinical trial for the treatment of delayed onset movement disorders in China.
IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.
Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.
RECOMMEND
